How the expanded manufactury of five million prescriptions for its weight-loss drugs failed FDA inspection :hmn
An Ozempic and Wegovy plant in North Carolina that helps serve millions of Americans has failed inspection, reports show. The Food and Drug Administration (FDA) determined that the factory had “offensive” conditions. The drugmaker, based in Clayton, North Carolina, now has three weeks to create an action plan to resolve the issues or risk further …